Cargando…
Preoperative detection of TERT promoter and BRAF(V600E) mutations in papillary thyroid carcinoma in high-risk thyroid nodules
OBJECTIVES: This observational study analyzed telomerase reverse transcriptase (pTERT) mutations in 45 fine-needle aspiration (FNA) specimens obtained from thyroid nodules followed by postoperatively confirmation of papillary thyroid cancer (PTC) diagnosis, examining their relationship with clinicop...
Autores principales: | Giorgenon, Tatiana Marina Vieira, Carrijo, Fabiane Tavares, Arruda, Maurício Alamos, Cerqueira, Taíse Lima Oliveira, Barreto, Haiara Ramos, Cabral, Juliana Brandão, da Silva, Thiago Magalhães, Magalhães, Patrícia Künzle Ribeiro, Maciel, Léa Maria Zanini, Ramos, Helton Estrela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Endocrinologia e Metabologia
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522131/ https://www.ncbi.nlm.nih.gov/pubmed/30916166 http://dx.doi.org/10.20945/2359-3997000000116 |
Ejemplares similares
-
Medullary thyroid carcinoma – Adverse events during systemic treatment: risk-benefit ratio
por: Maciel, Léa Maria Zanini, et al.
Publicado: (2017) -
Association between BRAF (V600E) mutation and clinicopathological features of papillary thyroid carcinoma: a Brazilian single-centre case series
por: Pessôa-Pereira, Danielle, et al.
Publicado: (2019) -
HOPX homeobox methylation in differentiated thyroid cancer and its clinical relevance
por: Lima, Erika Urbano, et al.
Publicado: (2018) -
BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients
por: Sun, Jian, et al.
Publicado: (2016) -
BRAF, TERT and HLA-G Status in the Papillary Thyroid Carcinoma: A Clinicopathological Association Study
por: Bertol, Bruna C., et al.
Publicado: (2023)